Table 2 Association between Cangrelor use and baseline/procedural features.

From: Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry

 

Univariate logistic regression analysis

Multivariate logistic regression analysis

95% C.I

OR

p

95% C.I

OR

p

Age

0.998

1.027

1.012

0.090

    

Female

0.843

1.837

1.245

0.271

    

STEMI

0.961

1.872

1.341

0.085

    

Diabetes mellitus

0.431

0.972

0.647

0.036

0.464

1.099

0.714

0.126

Arterial hypertension

0.800

1.765

1.188

0.392

    

Dyslipidaemia

0.971

1.956

1.378

0.073

    

Smoking

0.715

1.442

1.016

0.931

    

Obesity

0.648

1.510

0.989

0.960

    

Prior PCI/coronary bypass

0.422

0.966

0.638

0.034

0.767

2.975

1.511

0.232

Prior AMI

0.285

0.765

0.467

0.003

0.144

0.708

0.319

0.005

Prior Bleeding

1.251

20.404

5.052

0.023

1.314

24.175

5.636

0.020

Peripheral artery disease

0.651

2.256

1.212

0.544

    

OAC use

0.528

1.703

0.948

0.858

    

CKD

0.845

1.864

1.255

0.261

    

LVEF < 30%

2.003

5.792

3.406

 < 0.001

1.968

6.102

3.465

 < 0.001

High-risk clinical profile

1.182

2.827

1.828

0.007

0.934

2.388

1.494

0.094

NIV

0.476

2.354

1.059

0.888

    

LM PCI

0.385

3.276

1.123

0.831

    

LAD PCI

0.805

1.559

1.120

0.500

    

CX PCI

0.440

1.028

0.672

0.067

    

RC PCI

0.718

1.474

1.028

0.878

    

Multivessel CAD

0.437

0.852

0.610

0.004

0.459

0.927

0.653

0.017

Complex PCI

0.785

1.826

1.197

0.404

    

Multivessel PCI

0.849

2.240

1.379

0.194

    

HBR-ARC

0.636

1.288

0.905

0.580

    
  1. STEMI ST-elevation myocardial infarction, pci percutaneous coronary intervention, AMI Acute myocardial infarction, OAC Oral anticoagulation, CKD Chronic kidney disease, LVEF Left ventricular ejection fraction, NIV Non invasive ventilation, LM Left main, LAD Left anterior descending coronary artery, Cx Circumflex coronary artery, RC Right coronary artery, CAD Coronary artery disease, HBR-ARC High bleeding risk according to Academic Research Consortium.
  2. Significant values are in [bold].
Back to article page